Phosphagen. Share Discussion Threads

[donaferentes] 14/12/2006 12:12

I guess the A$5k per holder will be geared to how many each currently holds and will possibly be restricted if oversubscribed. Looking forward to seeing the precise terms when published.

Long-term holder and firm supporter of this early stage company that has hit all milestones so far that I am aware of.

[ladybird1] 14/12/2006 08:59

Seems to have gone down well in Aus. Nearly 5 million shares traded & price back up sharply last night.

[lgw] 14/12/2006 08:01

The ball is in Nestles court now!

About the Phosphagenics Ltd/ Nestlé Nutrition Research Agreement

Under the terms of the agreement, Nestlé Nutrition has been contributing funding towards two full dose-response pre-clinical studies in return for obtaining an option to exclusively license Phospha-E® for use as a nutritional product, targeting the prevention and treatment of metabolic syndrome. Given that the pre-clinical trials are now complete, Nestlé Nutrition has the opportunity to exercise this licence option upon payment of an option fee.



If Nestlé Nutrition exercises this option, the agreement requires that Nestlé Nutrition will launch within 12 months of regulatory approval a product with health claims for metabolic syndrome, and that Phosphagenics will be responsible for the manufacture of, and sale to, Nestlé Nutrition of Phospha-E®.



Phospha-E®

Phospha-E® is a patented derivative of vitamin E that has superior properties compared to its parent molecule. For example, Phospha-E® has been shown to be better absorbed than vitamin E, both orally and through the skin, to lower cholesterol & triglycerides, prevent the formation of plaque in heart arteries, as well as having unique anti-inflammatory properties.



Phospha E® has applications across all three nutraceutical market segments, and is currently sold internationally as a dietary supplement by Zila Nutraceuticals Inc (under the name of Ester-ETM) and is marketed worldwide in the personal care market as Vital ETTM by ISP Corporation.



About metabolic syndrome

Metabolic syndrome is a multifactorial risk factor for cardiovascular disease and diabetes. The root causes of metabolic syndrome are overweight/obesity, physical inactivity, and genetic factors. It is estimated that about 27% of adults in the US have metabolic syndrome and that one in three overweight or obese people in the US have this condition. The condition is being diagnosed with increasing frequency.



Contact details:

Dr Esra Ogru

Phosphagenics Ltd

Executive Director Research & Development

[phone] or [phone]



Mr Harry Rosen

Phosphagenics Ltd

Managing Director

[phone] or [phone]

[suesean1] 14/12/2006 03:08

News out in Aus about Phospha-E trials.

[eriktherock] 13/12/2006 21:15

rambutan, sorry. PGI are a dead loss.

[rambutan2] 13/12/2006 21:14

you're right! usually uk holders are excluded from ssp's. will ring my broker tomorrow and see whether they agree, or whether there some snag...


About the Share Purchase Plan

Phosphagenics' Board of Directors has resolved to activate the Share Purchase
Plan ("SPP") to give eligible shareholders the opportunity to top up their
holdings in the Company's shares at a price of 30 cents per share. Registered
holders may subscribe for up to $A5,000 worth of new, fully paid ordinary
shares without brokerage costs and at a discount to the market price. The
number of shares to be issued under this underwritten SPP will be a minimum of
16.7 million and a maximum of 25.0 million.

The right to participate in the SPP is available exclusively to Australian, New
Zealand and United Kingdom shareholders who are registered as holders of fully
paid ordinary shares as at 5.00pm (Australian Eastern Standard Time) on 18
December 2006. Full details of the SPP will be set out in the letter which will
be mailed to eligible shareholders.

The key plan dates are:

1: Record date to establish entitlement to participate - 18 December 2006

2: Despatch of documents to eligible shareholders - 20 December 2006

3: Closing date - 19 January 2007

4: Issues of shares (subject to cleared funds) - 24 January 2007

5: Trading of new shares - 29 January 2007

This plan is being underwritten to the value of $A5.0 million (16.7 million
shares) by BBY Limited.

[estseon] 13/12/2006 09:38

UK shareholders will have the opportunity to subscribe for up to A$5,000 worth of shares. Record date is 18th December. Close date is 19th January. It's all in the RNS.

[rambutan2] 12/12/2006 00:06

trouble with asx/aims is that aim holders don't get the opps offered to oz investors. still, 12p isn't a disaster and i'm in a similar sort of boat to donaferentes.

[donaferentes] 11/12/2006 23:34

long-term hold for me on a smallish investment, expecting it to be 5-bagger or similar after 3-5 years. if more actiive I'd uuse the money else where for now, bu tthen I'd miss the entry point for sure.

susean - thanks for the answer to part 2.

[suesean1] 11/12/2006 23:30

Phases 3,4 and so on.

[suesean1] 11/12/2006 23:27

Quick off the mark Donaferentes.

[donaferentes] 11/12/2006 23:25

= 12p pretty much = 11% discont - fair enough. what for - anyone know?

[suesean1] 11/12/2006 23:24

News out in Aus, 30 cents per share $10 Million to be raised.

[suesean1] 10/12/2006 12:52

I have asked the quetsion on a Aussie BB, a bit late in the night over there, lets see what comes back.

[worc0670] 09/12/2006 12:41

Never been involved in a capital raising before. Is this good news? or does it depend on the take up of new shares? Is it just like a placing?

[Abuse team] 09/12/2006 00:57

Post removed by ADVFN

[donaferentes] 08/12/2006 23:59

strange. shouldn't there be some announcement over here as to how much and what for? I guess I take it as a positive, but it would be nice to be told at the same time as the other side of the world.

[ladybird1] 08/12/2006 15:56

Still trading peacefully on LSE - got a quote no trouble.

[donaferentes] 06/12/2006 23:43

nice share

[waldron] 06/12/2006 07:38

nice thread

[ladybird1] 05/12/2006 10:18

Low volume, drifting gently recently on ASX. Usual small co.trend, until some news.

[suesean1] 05/12/2006 02:20

Now 2.7% down. Watching the cricket, bloody nightmare.

[suesean1] 05/12/2006 00:46

Down in oz 5.4%, no news on Hotcopper.

[donaferentes] 29/11/2006 07:42

We'll never know for sure!